Table 3.
Correlation 2000-2011 |
Statistical values |
|||
---|---|---|---|---|
Consumption of antibiotics | Bacterial resistance | R | p | |
Fluoroquinolones |
CIP |
KLPN |
0.0456 |
0.8797 |
|
|
ESCO |
0.0105 |
0.9721 |
|
|
ENCL |
-0.2355 |
0.4348 |
|
|
PRMI |
-0.1965 |
0.5146 |
Third- and fourth-generation cephalosporins |
CTZ |
KLPN |
0.2285 |
0.4486 |
|
|
ESCO |
0.068 |
0.8216 |
|
|
ENCL |
0.1439 |
0.6333 |
|
|
PRMI |
-0.6139 |
0.0417 |
Third- and fourth-generation cephalosporins |
PPT |
KLPN |
-0.1121 |
0.7101 |
|
|
ESCO |
0.0437 |
0.8848 |
|
|
ENCL |
-0.1329 |
0.6594 |
|
|
PRMI |
-0.4804 |
0.1111 |
Third- and fourth-generation cephalosporins |
CIP |
KLPN |
0.1053 |
0.727 |
|
|
ESCO |
0.2285 |
0.4486 |
|
|
ENCL |
-0.1371 |
0.6494 |
|
|
PRMI |
0.1263 |
0.6753 |
Piperacillin/tazobactam |
PPT |
KLPN |
0.8509 |
0.0048 |
|
|
ESCO |
0.8421 |
0.052 |
|
|
ENCL |
0.5009 |
0.0967 |
|
|
PRMI |
-0.175 |
0.5617 |
Piperacillin/tazobactam |
CTZ |
KLPN |
0.8398 |
0.0053 |
|
|
ESCO |
0.8855 |
0.0033 |
|
|
ENCL |
0.4921 |
0.1027 |
|
|
PRMI |
0.0679 |
0.8218 |
Aminoglycosides |
GEN |
KLPN |
0.6418 |
0.0333 |
|
|
ESCO |
0.6964 |
0.0209 |
|
|
ENCL |
0.523 |
0.0828 |
|
|
PRMI |
-0.6702 |
0.0262 |
Aminoglycosides |
AMI |
KLPN |
0.4135 |
0.1703 |
|
|
ESCO |
0.7441 |
0.0136 |
|
|
ENCL |
0.6307 |
0.0364 |
PRMI | -0.2708 | 0.369 |
R – Spearman’s rank correlation coefficient, p - statistical significance.